The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Pathologists’ diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study
Open accessAbstract
Objective To quantify the accuracy and reproducibility of pathologists’ diagnoses of melanocytic skin lesions. Design Observer accuracy and reproducibility study. Setting 10 US states. Participants Skin biopsy cases (n=240), grouped into sets of 36 or 48. Pathologists from 10 US states were randomized to independently interpret the same set on two occasions (phases 1 and 2), at least eight months apart. Main outcome measures Pathologists’ interpretations were condensed into five classes: I (eg, nevus or mild atypia); II (eg, moderate atypia); III (eg, severe atypia or melanoma in situ); IV (eg, pathologic stage T1a (pT1a) early invasive melanoma); and V (eg, ≥pT1b invasive melanoma). Reproducibility was assessed by intraobserver and interobserver concordance rates, and accuracy by concordance with three reference diagnoses. Results In phase 1, 187 pathologists completed 8976 independent case interpretations resulting in an average of 10 (SD 4) different diagnostic terms applied to each case. Among pathologists interpreting the same cases in both phases, when pathologists diagnosed a case as class I or class V during phase 1, they gave the same diagnosis in phase 2 for the majority of cases (class I 76.7%; class V 82.6%). However, the intraobserver reproducibility was lower for cases interpreted as class II (35.2%), class III (59.5%), and class IV (63.2%). Average interobserver concordance rates were lower, but with similar trends. Accuracy using a consensus diagnosis of experienced pathologists as reference varied by class: I, 92% (95% confidence interval 90% to 94%); II, 25% (22% to 28%); III, 40% (37% to 44%); IV, 43% (39% to 46%); and V, 72% (69% to 75%). It is estimated that at a population level, 82.8% (81.0% to 84.5%) of melanocytic skin biopsy diagnoses would have their diagnosis verified if reviewed by a consensus reference panel of experienced pathologists, with 8.0% (6.2% to 9.9%) of cases overinterpreted by the initial pathologist and 9.2% (8.8% to 9.6%) underinterpreted. Conclusion Diagnoses spanning moderately dysplastic nevi to early stage invasive melanoma were neither reproducible nor accurate in this large study of pathologists in the USA. Efforts to improve clinical practice should include using a standardized classification system, acknowledging uncertainty in pathology reports, and developing tools such as molecular markers to support pathologists’ visual assessments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Egner, J. R. (2010) · JAMA · doi:10.1001/jama.2010.1525 · Cited by 5,997
Problems of Spectrum and Bias in Evaluating the Efficacy of Diagnostic Tests
Ransohoff, D. F., & Feinstein, A. R. (1978) · New England Journal of Medicine · doi:10.1056/nejm197810262991705 · Cited by 1,734
Improving Diagnosis in Health Care
Committee on Diagnostic Error in Health Care, Board on Health Care Services, Institute of Medicine, & The National Academies of Sciences, E. (2015) · doi:10.17226/21794 · Cited by 1,376
The Genetic Evolution of Melanoma from Precursor Lesions
Shain, A. H., Yeh, I., Kovalyshyn, I., Sriharan, A., Talevich, E., Gagnon, A., Dummer, R., North, J., Pincus, L., Ruben, B., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1502583 · Cited by 1,065
Shain, A. H., & Bastian, B. C. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.37 · Cited by 896
Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens
Elmore, J. G., Longton, G. M., Carney, P. A., Geller, B. M., Onega, T., Tosteson, A. N. A., Nelson, H. D., Pepe, M. S., Allison, K. H., Schnitt, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.1405 · Cited by 751 · cited 1×
“…lesions by current Although diagnostic discordance has been described in other areas of clinical medicine, 20 21 including pathologists diagnosing breast biopsies 22 and radiologists interpreting mammograms, 23 the findings reported here are more pronounced than in other disciplines of medicine.”
BackgroundSelf-citationInviting Patients to Read Their Doctors' Notes: A Quasi-experimental Study and a Look Ahead
Delbanco, T., Walker, J., Bell, S. K., Darer, J. D., Elmore, J. G., Farag, N., Feldman, H. J., Mejilla, R., Ngo, L., Ralston, J. D., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-7-201210020-00002 · Cited by 685
Self-citationVariability in Radiologists' Interpretations of Mammograms
Elmore, J. G., Wells, C. K., Lee, C. H., Howard, D. H., & Feinstein, A. R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312206 · Cited by 601
Self-citationFarmer, E. R., Gonin, R., & Hanna, M. P. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90157-4 · Cited by 440
Cited by
Rajkomar, A., Dean, J., & Kohane, I. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1814259 · Cited by 4,579
Current state of melanoma diagnosis and treatment
Davis, L. E., Shalin, S. C., & Tackett, A. J. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1640032 · Cited by 922
Automated machine learning: Review of the state-of-the-art and opportunities for healthcare
Waring, J., Lindvall, C., & Umeton, R. (2020) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2020.101822 · Cited by 834
Guidelines of care for the management of primary cutaneous melanoma
Swetter, S. M., Tsao, H., Bichakjian, C. K., Curiel-Lewandrowski, C., Elder, D. E., Gershenwald, J. E., Guild, V., Grant-Kels, J. M., Halpern, A. C., Johnson, T. M., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.08.055 · Cited by 727
Self-citationThe Rapid Rise in Cutaneous Melanoma Diagnoses
Welch, H. G., Mazer, B. L., & Adamson, A. S. (2021) · New England Journal of Medicine · doi:10.1056/nejmsb2019760 · Cited by 418
Deep neural networks are superior to dermatologists in melanoma image classification
Brinker, T. J., Hekler, A., Enk, A. H., Berking, C., Haferkamp, S., Hauschild, A., Weichenthal, M., Klode, J., Schadendorf, D., Holland-Letz, T., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.05.023 · Cited by 415
Pathologist-level classification of histopathological melanoma images with deep neural networks
Hekler, A., Utikal, J. S., Enk, A. H., Berking, C., Klode, J., Schadendorf, D., Jansen, P., Franklin, C., Holland-Letz, T., Krahl, D., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.04.021 · Cited by 231
An Epidemiologic Analysis of Melanoma Overdiagnosis in the United States, 1975–2017
Kurtansky, N. R., Dusza, S. W., Halpern, A. C., Hartman, R. I., Geller, A. C., Marghoob, A. A., Rotemberg, V. M., & Marchetti, M. A. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.12.003 · Cited by 65
Attitudes Toward Artificial Intelligence Within Dermatopathology: An International Online Survey
Polesie, S., McKee, P. H., Gardner, J. M., Gillstedt, M., Siarov, J., Neittaanmäki, N., & Paoli, J. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.591952 · Cited by 53
Defining the prognostic role of MicroRNAs in cutaneous melanoma
Dika, E., Riefolo, M., Porcellini, E., Broseghini, E., Ribero, S., Senetta, R., Osella-Abate, S., Scarfì, F., Lambertini, M., Veronesi, G., et al. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.03.949 · Cited by 39
Artificial Intelligence for Dermatopathology: Current Trends and the Road Ahead
Chen, S. B., & Novoa, R. A. (2022) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2022.01.003 · Cited by 37
Cazzato, G., Massaro, A., Colagrande, A., Lettini, T., Cicco, S., Parente, P., Nacchiero, E., Lospalluti, L., Cascardi, E., Giudice, G., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12081972 · Cited by 34
“Similarly, over time, the diagnoses of the so-called “gray zone” of dermatopathology lost intraobserver reproducibility [16].”
BackgroundUse of Artificial Intelligence in Skin Cancer Diagnosis and Management
Wada, M., Ge, Z., Gilmore, S. J., & Mar, V. J. (2020) · Medical Journal of Australia · doi:10.5694/mja2.50759 · Cited by 22
Wies, C., Schneider, L., Haggenmüller, S., Bucher, T.-C., Hobelsberger, S., Heppt, M. V., Ferrara, G., Krieghoff-Henning, E. I., & Brinker, T. J. (2024) · PLOS ONE · doi:10.1371/journal.pone.0297146 · Cited by 16
Digital quantification of Ki67 and PRAME in challenging melanocytic lesions—A novel diagnostic tool
Brogård, M. B., Steiniche, T., Lade-Keller, J., Wandler, A., Christensen, K. B., Georgsen, J. B., & Nielsen, P. S. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.155953 · Cited by 1
Metadata
- Authors
- Elmore, J. G., Barnhill, R. L., Elder, D. E., Longton, G. M., Pepe, M. S., Reisch, L. M., Carney, P. A., Titus, L. J., Nelson, H. D., Onega, T., Tosteson, A. N. A., Weinstock, M. A., Knezevich, S. R., & Piepkorn, M. W.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2017-06-28
- Volume
- 357
- Pages
- j2813
- ISSN
- 1756-1833 (ISSN-L)
- 0959-8138
- OpenAlex
- W2732701910
- Cited by
- 436
- References
- 46
- FWCI
- 15.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.